PeptideStack
5.2kquestions
20kanswers
220users

Is an SSA order from Chengdu likely to hold cold chain to Sweden?

Asked 1 Dec 2025Modified 6 months agoViewed 17k times
15

The case in front of me: SSA · Chengdu · Sweden.

I am at the decision point and I would rather think it through than improvise.

I would rather spend money on measurement than on redundancy.

How do I make this decision on evidence rather than on feel?

cold-chain
cold-chain

Keeping material within a temperature window from manufacture to use: phase-change packs versus dry ice, thermal mass, transit-lane temperature…

578 questions
international-shipping
international-shipping

Cross-border movement of research material: transit lanes and their thermal profiles, tracked versus untracked, declaration accuracy, and what…

471 questions
vendor-comparison
vendor-comparison

Side-by-side comparison of suppliers on measurable axes - independently confirmed purity and content, lead time, cold-chain handling,…

388 questions
shareeditfollowflag
KS
askedk_szabo27k271 Dec 2025

5 Answers

Sorted by votes
53

The short version: a spent cold pack on arrival is expected, the solid does not mind, and the pack was never going to last twelve days.

A pack that arrived hard tells you about the last day of transit only, since it will have melted and, if the ambient dropped, partially refrozen.

Degradation pathway by condition

PathwayDominant whenDetected by
DeamidationSolution, neutral to alkaline pHRP-HPLC, +1 Da on MS
OxidationLight, trace metals, peroxidesRP-HPLC, +16 Da on MS
HydrolysisSolution, extremes of pHRP-HPLC, fragment masses
AggregationAgitation, interfaces, high concentrationSEC, visual haze; often invisible on RP-HPLC
Freeze-concentration damageFreeze-thaw of buffered solutionSEC, loss of recovered content

A single-use temperature logger costs a few pounds, records the whole journey and converts an argument into a record. If the history matters, this is the answer.

A cold pack tells you nothing about the eleven days before the last one.

Lyophilised tolerates the lane. That is the answer for almost every order.

shareimprove this answerflag
GH
answeredgreta_holzmann23k2726 Jan 2026
Sponsored

Sigma-Aldrich - Certified Reference Materials

Analytical standards and reagents with traceable certificates. Every quantitative result you read inherits the accuracy of the standard behind it.

Shop standards
36

The honest answer is that the cold pack is doing much less than people think and that shipping lyophilised is what actually protects the material.

A single phase-change pack in a thin-walled box holds below ten degrees for roughly one to two days at twenty-five degrees ambient, and under a day at thirty-five. On a nine-to-fourteen-day lane the material is at ambient for most of the journey whatever was packed with it.

Asking a supplier to hold a shipment during a heatwave is reasonable and the better ones agree; the cost is a week and the benefit is a shorter warm exposure for anything in solution.

Phase-change pack hold time is a function of mass, latent heat and insulation, and published figures for small parcels are on the order of one to two days.

Nothing here is medical advice, and research-use compounds are not approved for human use.

Buy a logger if you actually want to know. Everything else is inference.

shareimprove this answerflag
WO
answeredw_okoye43k13715 Jan 2026
26

The relevant physics is latent heat: a phase-change pack holds temperature only while it is changing phase, and once it has melted it is a warm mass.

Once the parcel arrives, the domestic leg is the controllable part: get it into the refrigerator promptly rather than leaving it in a warm hallway for a day.

On the detail: that is the argument for shipping lyophilised rather than for shipping colder. A dry powder with low residual moisture is stable at ambient for months; the pathways that matter need water.

The caveat is that a warm transit is survivable for a solid and materially different for a solution.

Solutions are a different question and deserve the worry the solids get.

shareimprove this answerflag
PC
answeredpk_curve30k284 Jan 2026
The doubling-per-ten-degrees rule is the part I did not know and now use constantly. – marta_okonkwo 5 months ago
add a comment
20

Start with the physical state, because it changes the answer completely and is the first thing to establish.

Arrhenius behaviour means the degradation rate roughly doubles per ten degrees. A week at thirty degrees is therefore a meaningful exposure for a solution and an immaterial one for a dry solid.

Solid-state stability of lyophilised peptides at ambient temperature is documented in formulation studies with residual moisture as the dominant variable.

A liquefied pack is expected. It is not evidence of a problem.

shareimprove this answerflag
TM
answeredtobias_maartens171k35813 Dec 2025
8Two lots stored differently, reassayed at a year — the difference was smaller than I expected. – Dr_Wren_Halliday 8 months ago
add a comment
-2

Answer first: for a lyophilised solid the cold chain matters far less than people believe, and for a solution it matters far more than they act as though it does.

Anything shipped in solution is a different risk category, because hydrolysis and deamidation proceed in the aqueous phase and are strongly temperature-dependent.

Single-use temperature loggers are standard practice in supply chains where temperature genuinely matters and are inexpensive at parcel scale.

The domestic leg is the part you control. Refrigerate it promptly.

edited 30 Dec 2025 by marta_okonkwo — expanded the table to cover the lower concentration

shareimprove this answerflag
MO
answeredmarta_okonkwo190k25824 Dec 2025
2Adding a vote because this deserves more of them. – lane_transit 3 months ago
Thank you — this is the answer I was looking for. – h_villanueva 36 days ago
add a comment

Your answer

Ask PeptideStack is a static archive. Posting is closed, but the norms are worth stating: answer the question that was asked, show your working, cite the trial or the certificate, and say plainly where the evidence runs out.

Not medical advice. Research-use-only compounds are not approved for human use.